Skip to main navigation Skip to search Skip to main content

Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: Avoiding a serious adverse drug interaction

  • Brad Moriyama
  • , Oluwaseun Falade-Nwulia
  • , Janice Leung
  • , Scott R. Penzak
  • , Caroline Jjingo
  • , Xuan Huang
  • , Stacey A. Henning
  • , Wyndham H. Wilson
  • , Thomas J. Walsh

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e877-e879
JournalMycoses
Volume54
Issue number6
DOIs
StatePublished - Nov 2011
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this